Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

BRTX
BioRestorative Therapies, Inc. Common Stock (NV)
stock NASDAQ

At Close
Jul 13, 2026 3:47:38 PM EDT
0.3400USD-1.565%(-0.0050)186,722
0.2900Bid   0.4100Ask   0.1300Spread
Pre-market
Jul 10, 2026 9:28:30 AM EDT
0.3513USD+1.826%(+0.0063)0
After-hours
Jul 10, 2026 4:29:30 PM EDT
0.3516USD+5.144%(+0.0172)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 26, 2022
06:00AM EST  BioRestorative Therapies Named One of Ten Most Innovative   GlobeNewswire Inc
Jan 11, 2022
06:14AM EST  BioRestorative Therapies Names Robert Paccasassi To VP Of Quality Assurance/Regulatory Compliance   RTTNews
06:00AM EST  BioRestorative Therapies Announces the Appointment of Robert   GlobeNewswire Inc
Jan 6, 2022
06:00AM EST  BioRestorative Therapies, Inc. (the Company" or BioRestorative) (NASDAQ:BRTX), a life sciences company focused on stem cell-based therapies, today announced that Lance Alstodt, its Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BioConnect 2022 Conference, being held virtually from January 10-13, 2022.   GlobeNewswire Inc
Jan 4, 2022
06:01AM EST  BioRestorative Therapies Awarded $256K STTR Phase I Grant To 'Explore the Therapeutic Effects of PEG-Peptide Hydrogel-Encapsulated Hypoxic Bone Marrow Stem Cells'   Benzinga
06:00AM EST  BioRestorative Therapies Awarded an STTR Phase I Grant to Explore   GlobeNewswire Inc
Dec 22, 2021
12:16PM EST  Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge   Benzinga
10:33AM EST  BioRestorative Therapies, Inc. (BRTX) shares are gaining more than 18 percent on Wednesday morning trade after the company announced a Master Service Agreement with the contract research organization - PRC Clinical for Phase 2 clinical trial.   RTTNews
10:23AM EST  Mid-Morning Market Update: Markets Edge Higher; CarMax Profit Tops Estimates   Benzinga
Dec 21, 2021
04:02PM EST  BioRestorative Therapies Announces CRO Agreement With PRC Clinical For BRTX-100 Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease   Benzinga
04:01PM EST  BioRestorative Therapies, Inc. (the Company" or BioRestorative) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced it has entered into a Master Service Agreement with PRC Clinical, a contract research organization (CRO) specializing in clinical trial management to conduct BioRestoratives Phase 2 clinical trial.   GlobeNewswire Inc
06:00AM EST  BioRestorative Therapies, Inc. (the Company" or BioRestorative) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced its Chief Executive Officer, Lance Alstodt, will be featured on the James Hicks NewMedia Show on Tuesday, December 21st.   GlobeNewswire Inc
Dec 20, 2021
06:00AM EST  BioRestorative Therapies, Inc. (the Company" or BioRestorative) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today released the following year-end message.   GlobeNewswire Inc
Dec 2, 2021
06:11AM EST  BioRestorative Files Ten Patent Applications Related To BRTX-100 Program For Treating Chronic Lumbar Disc Disease   RTTNews
06:04AM EST  BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program   Benzinga
06:00AM EST  BioRestorative Therapies, Inc. (the Company" or BioRestorative) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based therapies, today announced that it has filed ten patent applications related to its BRTX-100 program for treating chronic lumbar disc disease with the United States Patent and Trademark Office (USPTO).   GlobeNewswire Inc
Dec 1, 2021
10:23AM EST  Roth Capital Initiates Coverage On BioRestorative Therapies with Buy Rating, Announces Price Target of $37   Benzinga
Nov 23, 2021
04:29PM EST  BioRestorative Therapies Files Form RW To Withdraw Offering   Benzinga
Nov 19, 2021
06:05AM EST  BioRestorative Therapies Reports Entered Letter Of Intent With PRC Clinical To Provide Start-Up Contact Research Organization Services For Co.'s BRTX-100 Phase 2 Trial   Benzinga
06:00AM EST  PRC Clinical to Provide Start-up CRO Services for BRTX-100 Phase 2 Clinical Trial   GlobeNewswire Inc
Nov 10, 2021
06:20AM EST  BioRestorative Therapies, Inc. (BRTX), a company focused on adult stem cell-based therapies, said on Wednesday that it has appointed Robert Kristal as Chief Financial Officer or CFO.   RTTNews
06:04AM EST  BioRestorative Therapies Appoints Robert Kristal As CFO   RTTNews
06:02AM EST  BioRestorative Therapies Named Robert Kristal as CFO   Benzinga
06:00AM EST  BioRestorative Therapies Appoints Robert Kristal as Chief   GlobeNewswire Inc
Nov 9, 2021
02:20PM EST  BioRestorative Therapies Announces Closing of $23 Million Public   GlobeNewswire Inc
Nov 5, 2021
10:19AM EDT  Mid-Morning Market Update: Markets Open Higher; US Economy Adds 531,000 Jobs   Benzinga
Oct 26, 2021
04:05PM EDT  BioRestorative Therapies Announces Implementation of Reverse Stock   GlobeNewswire Inc
08:00AM EDT  BioRestorative Therapies Announces Nomination of Two New Members   GlobeNewswire Inc
Sep 23, 2021
09:00AM EDT  BioRestorative Therapies, Inc. (BioRestorative or the Company) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Israeli Patent Office has issued BioRestorative a Notice of Allowanceforapatent applicationfor its metabolic ThermoStem program.   GlobeNewswire Inc
Sep 2, 2021
09:00AM EDT  Issued Patent Grants Protection for an Implantable Scaffold using Brown Adipose Derived Stem Cells and Methods of Use   GlobeNewswire Inc
Aug 31, 2021
09:00AM EDT  Patent Issued Grants Protection for Deriving Brown Adipocytes from Brown Adipose (Fat)-Derived Stem Cells   GlobeNewswire Inc
Aug 19, 2021
06:00AM EDT  BioRestorative Therapies Awarded One of Top 10 Spine Device   GlobeNewswire Inc
Aug 11, 2021
08:30AM EDT  BioRestorative Therapies, Inc. (the Company or BioRestorative) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today reminded its stockholders that its annual meeting of stockholders will be held on Tuesday, August 17, 2021 at 10 a.m. EDT.   GlobeNewswire Inc
Aug 9, 2021
11:58AM EDT  BioRestorative Therapies Announces Filing of Registration   GlobeNewswire Inc
Jun 7, 2021
07:00AM EDT  EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 9th Emerging Growth Conference.   GlobeNewswire Inc
06:00AM EDT  BioRestorative Therapies invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the online Emerging Growth Conference.   GlobeNewswire Inc
May 10, 2021
06:00AM EDT  BioRestorative Therapies, Inc. (the Company or BioRestorative) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it is initiating expansion of its Melville, New York based research laboratories to include capabilities for the clinical production of the Companys pipeline of clinical and investigational cell therapy candidates.   GlobeNewswire Inc
May 3, 2021
06:00AM EDT  BioRestorative Therapies Announces Compliance with SEC Reporting   GlobeNewswire Inc
Apr 5, 2021
06:28AM EDT  BioRestorative Therapies, Inc. (the Company or BioRestorative) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced the appointment of Nickolay V. Kukekov to the BioRestorative Board of Directors, effective March 18th, 2021.   GlobeNewswire Inc
Mar 31, 2021
07:03AM EDT  BioRestorative Therapies Announces Notice of Allowance for a New   GlobeNewswire Inc
Mar 22, 2021
06:00AM EDT  BioRestorative Therapies, Inc. (the Company) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the United States Patent Office and several International agencies have issued notices of allowance for three separate patent applications related to the Companys metabolic ThermoStem Program.   GlobeNewswire Inc
Mar 18, 2021
04:01PM EDT  BioRestorative Therapies Announces Filing of 2019 Annual Report on   GlobeNewswire Inc
Jan 5, 2021
08:00AM EST  BioRestorative Therapies, Inc. (BioRestorative or the Company) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced the following letter from its Chief Executive Officer, Lance Alstodt, to its shareholders and the investment community.   GlobeNewswire Inc
Nov 20, 2020
07:00AM EST  BioRestorative Therapies Emerges from Chapter 11 Reorganization   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC